These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 518692)

  • 1. Oncodazole (R 17934) an inhibitor of the turnover of phosphatidyl inositol in concanavalin A induced lymphocytes.
    Miller JJ
    Biochem Pharmacol; 1979 Oct; 28(19):2967-8. PubMed ID: 518692
    [No Abstract]   [Full Text] [Related]  

  • 2. Colchicine inhibits phosphatidylinositol turnover induced in lymphocytes by concavalin A.
    Schellenberg RR; Gillespie E
    Nature; 1977 Feb; 265(5596):741-2. PubMed ID: 859582
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of vinblastine, oncodazole, procarbazine, chlorambucil, and bleomycin in vivo on colchicine binding activity of tubulin.
    Brodie AE; Potter J; Reed DJ
    Life Sci; 1979 Apr; 24(17):1547-54. PubMed ID: 90323
    [No Abstract]   [Full Text] [Related]  

  • 4. Concanavalin A cap formation on human polymorphonuclear leukocytes induced by R17934, a new antitumor drug that interferes with microtubule assembly.
    Oliver JM
    J Reticuloendothel Soc; 1976 Jun; 19(6):389-95. PubMed ID: 940091
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of colchicine, vinblastine, griseofulvin and deuterium oxide upon phospholipid metabolism in concanavalin A-stimulated lymphocytes.
    Schellenberg RR; Gillespie E
    Biochim Biophys Acta; 1980 Sep; 619(3):522-32. PubMed ID: 7459363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tumor promoter enhances the phosphorylation of polyphosphoinositides while decreasing phosphatidylinositol labelling in lymphocytes.
    Boon AM; Beresford BJ; Mellors A
    Biochem Biophys Res Commun; 1985 Jun; 129(2):431-8. PubMed ID: 2990456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytomitogen induced changes in levels of inositol phosphates in the bovine lymphocytes.
    Dhingra JB; Verma NK; Behl R; Prasad SK; Ahlawat SP
    Indian J Biochem Biophys; 2005 Jun; 42(3):173-7. PubMed ID: 23923560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A correlation between in vivo and in vitro effects of the microtubule inhibitors colchicine, parbendazole and nocodazole on myxamoebae of Physarum polycephalum.
    Quinlan RA; Roobol A; Pogson CI; Gull K
    J Gen Microbiol; 1981 Jan; 122(1):1-6. PubMed ID: 6895648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin.
    Hoebeke J; Van Nijen G; De Brabander M
    Biochem Biophys Res Commun; 1976 Mar; 69(2):319-24. PubMed ID: 1267789
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of phosphatidylinositol turnover by concanavalin A is not sufficient to activate mouse thymocytes.
    Feister AJ; Sage HJ
    Biochem Biophys Res Commun; 1986 Dec; 141(2):657-64. PubMed ID: 3026388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of plasminogen activator expression and induction of DNA synthesis by microtubule-disruptive drugs.
    Chou IN; Zeiger J; Solomon JA; Black PH
    Biochem Biophys Res Commun; 1981 Aug; 101(4):1266-73. PubMed ID: 7197932
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues.
    Kruse LI; Ladd DL; Harrsch PB; McCabe FL; Mong SM; Faucette L; Johnson R
    J Med Chem; 1989 Feb; 32(2):409-17. PubMed ID: 2913301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of a new antimitotic agent, NSC-181928, with purified tubulin.
    Hamel E; Lin CM
    Biochem Biophys Res Commun; 1982 Feb; 104(3):929-36. PubMed ID: 6122449
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of anchorage-modulating doses of concanavalin A, microtubule-disrupting drugs and microfilament perturbants, cytochalasins, on the phosphatidylinositol response of rat lymph-node cells.
    Sasaki T; Hasegawa-Sasaki H
    Biochim Biophys Acta; 1981 Dec; 649(2):449-54. PubMed ID: 7317409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocodazole inhibition of the vasopressin-induced water permeability increase in toad urinary bladder.
    Brady RJ; Parsons RH; Coluccio LM
    Biochim Biophys Acta; 1981 Sep; 646(3):399-401. PubMed ID: 7284368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concanavalin A-induced modification of the electrophoretic mobility of lymphocytes. Effect of colchicine and cytochalasin B.
    Sainis KB; Forrester JA; Phondke CP
    Biochim Biophys Acta; 1981 Apr; 643(1):134-9. PubMed ID: 7236682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of various mitogens on the phospholipid metabolism of human peripheral lymphocytes.
    Masuzawa Y; Osawa T; Inoue K; Nojima S
    Biochim Biophys Acta; 1973 Dec; 326(3):339-44. PubMed ID: 4359864
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans.
    Davidse LC; Flach W
    J Cell Biol; 1977 Jan; 72(1):174-93. PubMed ID: 12184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical effects of luxabendazole on Trichinella spiralis.
    Criado-Fornelio A; de Armas-Serra C; Jimenez-Gonzalez A; Casado-Escribano N; Rodriguez-Caabeiro F
    Parasitol Res; 1990; 76(6):518-20. PubMed ID: 2381894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of benzimidazole carbamates with mammalian microtobule protein.
    Ireland CM; Gull K; Gutteridge WE; Pogson CI
    Biochem Pharmacol; 1979 Sep; 28(17):2680-2. PubMed ID: 518680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.